Yanfeng
Ding
ab,
Zhimin
Li
bc,
Wenwen
Hu
d,
Xianjing
Feng
e,
Ying
Chen
d,
Guohua
Yan
bf,
Yonglin
Wang
b,
Bo
Zhu
ab,
Wei
Yao
ab,
Li
Zheng
*ab,
Maolin
He
*c,
Ming
Gao
*ab and
Jinmin
Zhao
abfg
aGuangxi Collaborative Innovation Center for Biomedicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. E-mail: zhengli224@163.com; gaoming1983125@hotmail.com; Fax: +86-07715540585; Tel: +86-07715540585
bGuangxi Engineering Center in Biomedical Materials for Tissue and Organ Regeneration, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China
cDivision of Spine Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China. E-mail: 274783289@qq.com; Fax: +86-07715350189; Tel: +86-07715350189
dLife Sciences Institute, Guangxi Medical University, Nanning, 530021, China
ePharmaceutical College, Guangxi Medical University, Nanning, 530021, China
fDepartment of Orthopaedics Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China
gGuangxi Key Liboratory of Regenerative Medicine, Guangxi Medical University, Nanning, 530021, China
First published on 6th March 2023
Correction for ‘Carbazate-modified cross-linked dextran microparticles suppress the progression of osteoarthritis by ROS scavenging’ by Yanfeng Ding, et al., Biomater. Sci., 2021, 9, 6236–6250. https://doi.org/10.1039/D1BM00743B.
An independent expert has viewed the corrected Fig. 8 and confirmed that it is consistent with the discussions and conclusions presented.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2023 |